InsiderTrades

Form 4 for VTR Ventas

Accepted 2022-05-04 00:00:00 ET · period of report 2022-05-02 · accession 0000740260-22-000122 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-05-04 2022-05-02 VTR CAFARO DEBRA A COB, CEO, Dir M - OptEx $55.50 +17.4K 785.4K +2% +$965.7K
D 2022-05-04 2022-05-02 VTR CAFARO DEBRA A COB, CEO, Dir S - Sale+OE $55.72 -17.4K 768.0K -2% -$969.5K
D 2022-05-04 2022-05-02 VTR CAFARO DEBRA A COB, CEO, Dir M - OptEx $0.00 -17.4K 2.02M -0.9% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-05-02 M A 17,400 $55.50 785,360 D — — (F1) The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 19, 2021.
2 Common Common Stock 2022-05-02 S D 17,400 $55.72 767,960 D — — (F1) The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 19, 2021. (F2) The price reported is a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $55.65 to $56.20, inclusive. The Reporting Person undertakes to provide Issuer, any security holder of Issuer or the staff of the SEC, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
3 Derivative Stock Option (Right to Buy) 2022-05-02 M D 17,400 $0.00 2,017,673 D $55.50 · 2013-01-23 to 2023-01-23 17,400 Common Stock (F1) The transaction involved the exercise of fully vested options scheduled to expire in the next 12 months and the sale of the underlying shares net of the exercise price and taxes, all pursuant to a Rule 10b5-1 trading plan entered into by the Reporting Person on March 19, 2021. (F5) Fully vested.